Open an account

BioForce Nanosciences Holdings

BFNH · OTC

$6.70−$0.172 (−2.50%)TodayMarket closed ·
Prev close $6.87

About BFNH

BioForce Nanosciences Holdings, Inc. engages in the provision of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The company is headquartered in Virginia Beach, Virginia and currently employs 3 full-time employees. The company went IPO on 2005-10-11. The firm markets its products through social media and telemarketing. The firm seeks to expand its BioForce Eclipse nutritional powder for use in households throughout the United States. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, focus on being the channels for the Company’s Eclipse product lines. The firm privately labels the powder through a manufacturer located in Virginia. The firm caters to the needs of customers with a focus on the elderly and athletes across numerous sports, ages, and economic backgrounds. The firm also focuses on offering its products for direct sale on its Website at www.bioforceeclipse.com. The Company’s wholly owned subsidiary is Element Global, Inc.

Employees
3
Headquarters
Virginia Beach, Virginia
Listed
Oct 11, 2005
Sector
Consumer Staples
Industry
Personal Care Products
Website
bioforceeclipse.com

BFNH key statistics

Market cap
224.78M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
8.10K
Volume
3.72K
Open price
$6.81
High today
$6.89
Low today
$6.57
52 Week high
$10.99
52 Week low
$0.18

BioForce Nanosciences Holdings (BFNH) at a glance

As of Oct 20, 2026, BioForce Nanosciences Holdings (BFNH) shares are priced at $6.70, giving the company a market cap of 224.78M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $6.57 and $6.89. The current price is 2.0% above the day's low and 2.8% below its high.

Volume so far is 3.72K shares, below the average of 8.10K shares a day.

Over the past year BioForce Nanosciences Holdings has ranged from $0.18 to $10.99, and now sits 60% of the way up that range.

BioForce Nanosciences Holdings met or beat analyst EPS estimates in 5 of the last 5 quarters. In Q2 FY26 it reported $0.01 per share against an estimate of $0.00.

BFNH earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 5 quarters, by 30.1% on average.

  1. Q4 FY07: reported -$0.10 per share against an estimate of -$0.204
  2. Q3 FY08: reported -$0.15 per share against an estimate of -$0.153
  3. Q4 FY08: reported -$0.05 per share against an estimate of -$0.153
  4. Q4 FY25: reported $0.00 per share against an estimate of $0.00
  5. Q2 FY26: reported $0.01 per share against an estimate of $0.00

Similar companies

Companies in the same industry as BioForce Nanosciences Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.